Foamy microglia link oxylipins to disease progression in multiple sclerosis
D. van der Vliet, X. Di, Tatiana M. Shamorkina, Claire Coulon-Bainier, Anto Pavlovic, I.A.C.M. van der Vliet, Y. Zeng, Will Macnair, Noëlle van Egmond, J.Q.A. Chen, A.M.R. van den Bosch, Hendrik J. Engelenburg, Dennis D. Wever, M.R.J. Mason, Wouter P. F. Driever, , Mario van der Stelt
The paper identifies foamy microglia as contributors to disease progression in secondary progressive MS, linking oxylipins to lesion expansion and proposing monoacylglycerol lipase as a therapeutic target.
Leiden Repository (Leiden University) · Jan 1, 2026Peer-reviewedNeuroscience